Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections
This study has been completed.
Study NCT00480675   Information provided by Johns Hopkins University
First Received: May 30, 2007   Last Updated: January 27, 2009   History of Changes

May 30, 2007
January 27, 2009
March 2007
May 2008   (final data collection date for primary outcome measure)
Numerical pain scores [ Time Frame: 1 and 3 month post-injection ] [ Designated as safety issue: No ]
Numerical pain scores [ Time Frame: 1 and 3 month post-injection ]
Complete list of historical versions of study NCT00480675 on ClinicalTrials.gov Archive Site
SF-36, Oswestry Disability Index, Satisfaction [ Time Frame: 1 and 3 months post-injection ] [ Designated as safety issue: No ]
SF-36, Oswestry Disability Index, Satisfaction [ Time Frame: 1 and 3 months post-injection ]
 
Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections
 

The goals of our research project are to study the relationship, if any, between the success of a TB injection (measured by pain relief and general patient satisfaction) and the method in which it was placed. Because fluoroscopy places patients requires a slight risk from radiation exposure and increased cost versus blind injection, it is important to know if there is an advantage to using this technique. The investigators will randomize 64 patients to receive either trochanteric bursa injections with corticosteroid and local anesthetic guided by fluoroscopy, or trochanteric bursa patients to receive trochanteric bursa injections based on landmarks on palpation. The investigators will then determine which method is superior, and whether injecting steroid and local anesthetic into the bursa itself is superior or inferior to injecting it into a tender area outside the bursa.

This will be a randomized, controlled study evaluating the value of fluoroscopy in trochanteric bursa injections. Subjects will be recruited solely from the patients we normally see at the Blaustein Pain Treatment Center with a clinical diagnosis of GTPS. Sixty-four patients will be randomized in a 1:1 ratio using sealed envelopes to receive either TB corticosteroid injection done blind or with fluoroscopy. All patients who provide informed consent will be brought into the fluoroscopy suite and placed in the lateral decubitus position. In the patients randomized to receive fluoroscopically guided injections, a 22-gauge needle will be placed into the TB and correct position confirmed by fluoroscopy and contrast injection (1 ml per attempt) before corticosteroid and local anesthetic injection (60 mg of depomedrol and 2.5 ml of 0.5% bupivacaine). In the blinded group, one sham, pulsed fluoroscopic image will be taken of the femur, and the injection will be done based only on physical exam (overlying the area of maximal tenderness) and landmarks. Prior to the injection, 1 ml of contrast will be administered and another image taken to determine whether or not the needle is within the bursa, but this will not alter the injection. After contrast administration, the same corticosteroid and bupivacaine injection will be administered. The 2 main questions we propose to answer are: 1) whether using fluoroscopy for TB injections results in improved outcomes (comparison of the 32 patients in each group); and 2) whether injecting into the bursa provides superior results than performing non-bursal injections into the area of maximal tenderness (comparison of 32 patients who receive fluoroscopically-guided bursa injections + those patients whose blinded injection was noted to be intra-bursal vs. those patients whose blinded injection was extra-bursal).

 
Interventional
Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Bursitis
  • Procedure: trochanteric bursa injection done under fluoroscopy with depomedrol and bupivacaine
  • Procedure: Trochanteric bursa injection with depomedrol and bupivacaine
  • Experimental: Trochanteric bursa injections done into the bursa under fluoroscopic guidance
  • Active Comparator: Trochanteric bursa injection done with sham fluoroscopy using only landmarks as guidance.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
65
May 2008
May 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age > 18 years
  • Clinical diagnosis of trochanteric bursitis

Exclusion Criteria:

  • Pregnancy
  • Allergy to contrast
  • Untreated coagulopathy
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00480675
Johns Hopkins Office of Research Administration, Amanda Gibson
NA_00006986
Johns Hopkins University
 
Principal Investigator: Steven P Cohen, MD Johns Hopkins Medical Institutions
Johns Hopkins University
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP